Find the right fit for you - faster
Get tailored insights about working at Endologix in one quick step.
Endologix Snapshot
Our objective is to redefine the care of aortic aneurysms – to change the terms of reference for the care of those afflicted with this dangerous disease.
Our purpose as an organization is to “Revolutionize Aortic Care for Life.” This calls on each of us to demonstrate ownership in how we serve.
As we continue to grow, our core values and behaviors are even more important in helping us meet our commitments to our customers and patients.
Our purpose as an organization is to “Revolutionize Aortic Care for Life.” This calls on each of us to demonstrate ownership in how we serve.
As we continue to grow, our core values and behaviors are even more important in helping us meet our commitments to our customers and patients.
Founded in 1992, Endologix, Inc. is singularly focused on providing innovative, minimally invasive technologies for aortic disorders. Our current product offering includes a variety of endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA) and are protected by more than 108 patents.
Designed around key issues with challenging anatomies, difficult access and aneurysm sealing, Endologix products have been clinically proven in delivering positive patient outcomes. We are uniquely positioned to offer the most comprehensive product portfolio in AAA therapy.
Designed around key issues with challenging anatomies, difficult access and aneurysm sealing, Endologix products have been clinically proven in delivering positive patient outcomes. We are uniquely positioned to offer the most comprehensive product portfolio in AAA therapy.
